$5.83
0.437.96%
Últ. Act.: Nov 6, 4:42 PM
The average analyst price target for Cytek Biosciences is $5.15, 11.7% below the current price. Of 4 analysts, 3 rate it Buy and 1 Sell. Targets range from $3 to $7.50. The latest change came on May 13, 2026, when Stephens & Co. lowered its price target on Cytek Biosciences from $5.50 to $4.75 and kept an Overweight rating.
Price Target Range — 10 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months